Navigation Links
New Study on Cordyceps Sinensis (Hirsutella Sinensis) Shows Anti-Inflammatory Properties
Date:4/30/2013

Los Angeles, CA (PRWEB) April 30, 2013

Cordyceps sinensis is a medicinal fungus used for centuries in Asian countries as a health supplement and tonic. Traditionally prescribed by medical practitioners as a kidney and lung supplement, studies have found Cordyceps Sinensis’ impact on the human body reaches other functions as well, such as energy, fertility and anti-inflammation.*

Published in the March 5, 2013 issue of Scientific Journal, a new study details findings revealing Cordyceps Sinensis’ anti-inflammatory properties. These benefits were attributed to Cordyceps Sinensis’ ability to inhibit both canonical and non-canonical inflammasomes. Inflammasomes have been associated with several auto-inflammatory conditions such as gout. This study, performed at the Center for Molecular and Clinical Immunology at Chang Gung University in Taiwan, documents Cordyceps Sinensis’ suppression of interleukin-1ß and interleukin-18 secretion.

The study uses a specific anamorphic mycelial form of Cordyceps Sinensis known as Hirsutella Sinensis. This specific strain has proven to be rare and difficult to cultivate. Through Molecular Germplasm Identification, this particular strain of Cordyceps Sinensis' rDNA sequence matches wild-grown Cordyceps Sinensis by 99.645%, proving authenticity. Other strains on the market match only by 82.791%.

Download Cordyceps Sinensis (Hirsutella Sinensis) Clinical Trial

How to cite the study: Huang, T. et al. Hirsutella sinensis mycelium suppresses interleukin-1b and interleukin-18 secretion by inhibiting both canonical and non-canonical inflammasomes. Sci. Rep. 3, 1374; DOI:10.1038/srep01374 (2013).

*Legal Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Read the full story at http://www.prweb.com/releases/cordyceps-sinensis/hirstuella-sinensis/prweb10684567.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. New Study: Valtrex (Valacyclovir) Side Effects Target the Brain; polyDNA Suggests a Natural Herpes Remedy
2. Wysebridge Patent Bar Review Launches America Invents Act (AIA) Study Suite
3. Breath study brings roadside drug testing closer
4. Japan Bioinformatics Announces Release of a Case Study on Detecting SNPs and Short INDELs
5. Research Foundations Collaborate To Fund Phase 1 Study Of Cancer Drug In Alzheimers Disease Patients
6. Ceregene Reports Data From Parkinsons Disease Phase 2b Study
7. Study Says Kidney Bean Leaves Work Against Bed Bugs, My Cleaning Products Compares Its With a Non-Pesticide Bed Bug Spray
8. NeuroDerm Announces Enrollment in a Phase 2 Study of ND0612, a Continuous Levodopa/Carbidopa Drug for the Treatment of Parkinsons Disease
9. A bright idea: Tiny injectable LEDs help neuroscientists study the brain
10. Study Says Bed Bugs Show Resistance to Pesticides, My Cleaning Products Asserts Non-Pesticide Bed Bug Bully Is the Better Pick Against the Pests
11. Inflamax Research Chosen to Conduct a Multicenter Environmental Exposure Chamber Phase 3 Study of Ultrashort Grass Allergy Vaccine by Allergy Therapeutics (UK) Ltd.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, ... launch of their brand, UP4™ Probiotics, into Target stores nationwide. The company, which ... to add Target to its list of well-respected retailers. This list includes such ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. ... test has received AOAC Research Institute approval 061601. , “This is another AOAC-RI ... stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... , June 23, 2016 On ... session at 4,833.32, down 0.22%; the Dow Jones Industrial Average ... 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated coverage ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez ... Inc. (NASDAQ: BIND ). Learn more about these ...
Breaking Biology Technology:
(Date:6/2/2016)... 2016   The Weather Company , an IBM Business ... industry-first capability in which consumers will be able to interact ... questions via voice or text and receive relevant information about ... Marketers have long sought an advertising solution that can ... personal, relevant and valuable; and can scale across millions of ...
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC , ... announced the opening of an IoT Center of Excellence ... and expand the development of embedded iris biometric applications. ... level of convenience and security with unmatched biometric accuracy, ... identity aside from DNA. EyeLock,s platform uses video technology ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
Breaking Biology News(10 mins):